THROMBIN GENERATION TEST IN PATIENTS UNDER NEW ORAL ANTICOAGULANTS (DABIGATRAN AND RIVAROXABAN)

被引：0
|
作者：
Cabrera, N. [1 ]
Moret, A. [1 ]
Mesa, E. [1 ]
Vila, V. [1 ]
Mira, Y. [1 ]
Ferrando, F. [1 ]
Aznar, Jose A. [1 ]
Bonanad, S. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Unidad Hemostasia & Trombosis, Valencia, Spain
来源：
THROMBOSIS RESEARCH | 2014年 / 133卷
关键词：
D O I：
10.1016/S0049-3848(14)50148-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C0416
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [21] Circulating concentration of rivaroxaban or dabigatran anticoagulants in clinically selected patients
    Needham, J.
    Lewis, H.
    McMullen, A.
    Everington, T.
    Rangarajan, S.
    Mangles, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 641 - 641
  • [22] Prevalence of Intracardiac Thrombi Under Phenprocoumon, Direct Oral Anticoagulants (Dabigatran and Rivaroxaban), and Bridging Therapy in Patients With Atrial Fibrillation and Flutter
    Zylla, Maura M.
    Pohlmeier, Mara
    Hess, Alexander
    Mereles, Derliz
    Kieser, Meinhard
    Bruckner, Thomas
    Scholz, Eberhard
    Zitron, Edgar
    Schweizer, Patrick A.
    Katus, Hugo A.
    Thomas, Dierk
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (05): : 635 - 640
  • [23] A nationwide Belgian survey on the influence of the new oral anticoagulants dabigatran and rivaroxaban on commonly used coagulation assays
    Van Blerk, M.
    Bailleul, E.
    Chatelain, B.
    Demulder, A.
    Devreese, K.
    Douxfils, J.
    Jochmans, K.
    Mullier, F.
    Wijns, W.
    Soumali, M. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 263 - 263
  • [24] Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
    Steiner, T.
    Boehm, M.
    Dichgans, M.
    Diener, H. -C.
    Ell, C.
    Endres, M.
    Epple, C.
    Grond, M.
    Laufs, U.
    Nickenig, G.
    Riess, H.
    Roether, J.
    Schellinger, P. D.
    Spannagl, M.
    Veltkamp, R.
    CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (06) : 399 - 412
  • [25] Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban
    T. Steiner
    M. Böhm
    M. Dichgans
    H.-C. Diener
    C. Ell
    M. Endres
    C. Epple
    M. Grond
    U. Laufs
    G. Nickenig
    H. Riess
    J. Röther
    P. D. Schellinger
    M. Spannagl
    R. Veltkamp
    Clinical Research in Cardiology, 2013, 102 : 399 - 412
  • [26] Direct oral anticoagulants (DOACs) - dabigatran, rivaroxaban, apixaban, edoxaban - addition - EML
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 339 - 355
  • [27] Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study
    Antia, Camila
    Hone, Natalie
    Gloster, Hugh
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (05) : 967 - 968
  • [28] Effects of direct oral anticoagulants dabigatran and rivaroxaban on the blood coagulation function in rabbits
    Yin, Lu
    Qi, Yuan
    Ge, Zhiru
    Li, Jiajin
    OPEN LIFE SCIENCES, 2022, 17 (01): : 1 - 9
  • [29] What Is The Best Time Sampling For The Two Direct Oral Anticoagulants, Dabigatran and Rivaroxaban?
    Douxfils, Jonathan
    Classen, Jean-Francois
    Baudar, Justine
    Devalet, Berangere
    Samama, Meyer Michel
    Chatelain, Bernard
    Dogne, Jean-Michel
    Mullier, Francois
    BLOOD, 2013, 122 (21)
  • [30] Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban
    Tsuruya, Yuri
    Nakanishi, Takeo
    Komori, Hisakazu
    Wang, Xinying
    Ishiguro, Naoki
    Kito, Tomoko
    Ikukawa, Kouji
    Kishimoto, Wataru
    Ito, Sumito
    Schaefer, Olaf
    Ebner, Thomas
    Yamamura, Norio
    Kusuhara, Hiroyuki
    Tamai, Ikumi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2524 - 2534
12345